4D Molecular Therapeutics Ownership | Who Owns 4D Molecular Therapeutics?
4D Molecular Therapeutics Ownership Summary
4D Molecular Therapeutics is owned by 82.52% institutional investors, 2.67% insiders, and 14.81% retail investors. Blackrock is the largest institutional shareholder, holding 9.94% of FDMT shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.32% of its assets in 4D Molecular Therapeutics shares.
FDMT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | 4D Molecular Therapeutics | 82.52% | 2.67% | 14.81% |
| Sector | Healthcare Stocks | 247.07% | 12.15% | -159.22% |
| Industry | Biotech Stocks | 385.89% | 11.79% | -297.68% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 4.90M | 9.94% | $102.79M |
| Janus henderson group | 5.25M | 9.06% | $48.87M |
| Ra capital management | 5.05M | 7.42% | $67.16M |
| Blackrock funding, inc. /de | 4.72M | 6.72% | $67.61M |
| Goldman sachs group | 4.26M | 6.26% | $56.64M |
| Vanguard group | 3.09M | 5.51% | $23.20M |
| Novo | 3.25M | 4.77% | $43.21M |
| Bvf inc/il | 2.88M | 4.23% | $38.29M |
| T. rowe price investment management | 2.51M | 3.69% | $33.41M |
| State street | 2.47M | 3.51% | $35.34M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Acuta capital partners | 507.80K | 4.71% | $6.75M |
| Novo | 3.25M | 2.51% | $43.21M |
| Propel bio management | 179.15K | 1.36% | $2.56M |
| Parkman healthcare partners | 948.18K | 1.29% | $12.61M |
| Catalio capital management, lp | 471.25K | 1.18% | $6.27M |
| Bvf inc/il | 2.88M | 0.98% | $38.29M |
| Diadema partners lp | 571.11K | 0.96% | $7.60M |
| Ra capital management | 5.05M | 0.58% | $67.16M |
| Persistent asset partners | 106.95K | 0.42% | $1.53M |
| Opaleye management | 334.44K | 0.40% | $4.45M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| T. rowe price investment management | 2.51M | 0.02% | 2.51M |
| Adage capital partners gp | 2.25M | 0.04% | 644.05K |
| Blackrock | 4.90M | 0.00% | 612.35K |
| Janus henderson group | 5.25M | 0.02% | 611.28K |
| Morgan stanley | 1.09M | 0.00% | 587.63K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Viking global investors lp | - | - | -2.93M |
| Point72 asset management | - | - | -1.54M |
| Braidwell lp | - | - | -1.23M |
| Casdin capital | - | - | -1.15M |
| Polar capital | - | - | -838.49K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| T. rowe price investment management | 2.51M | 0.02% | 2.51M | $33.41M |
| Diadema partners lp | 571.11K | 0.96% | 571.11K | $7.60M |
| Acuta capital partners | 507.80K | 4.71% | 507.80K | $6.75M |
| Norges bank | 500.82K | 0.00% | 500.82K | $2.79M |
| Catalio capital management, lp | 471.25K | 1.18% | 471.25K | $6.27M |
Sold Out
| Holder | Change |
|---|---|
| Clearstead advisors | -3.00 |
| Innealta capital | -4.00 |
| Nelson, van denburg & campbell wealth management group | -8.00 |
| Advisory services network | -8.00 |
| Mai capital management | -18.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | 172 | 3.61% | 57,988,971 | -0.69% | 82 | 1.12% | 86 | -9.47% | 42 | 7.69% |
| Jun 30, 2026 | 165 | 5.10% | 58,390,194 | 15.35% | 85 | 1.55% | 95 | 37.68% | 38 | -19.15% |
| Mar 31, 2026 | 151 | -2.58% | 49,527,045 | -7.29% | 85 | 0.94% | 68 | -21.84% | 46 | 24.32% |
| Dec 31, 2025 | 40 | -70.59% | 5,592,450 | -85.86% | 9 | 0.20% | 21 | -69.12% | 10 | -77.78% |
| Sep 30, 2025 | 39 | -65.49% | 6,758,953 | -80.69% | 12 | 0.31% | 21 | -62.50% | 11 | -69.44% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 1.54M | 3.32% | - |
| Vanguard Total Stock Mkt Idx Inv | 1.59M | 3.04% | -65.87K |
| Vanguard Morn Total Stk Mkt Idx Investor | 1.59M | 3.04% | -65.87K |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.59M | 2.88% | - |
| State Street® SPDR® S&P® Biotech ETF | 1.26M | 2.28% | 33.00K |
| SPDR® S&P Biotech ETF | 986.40K | 2.13% | 14.03K |
| iShares Russell 2000 ETF | 1.15M | 2.09% | - |
| Janus Henderson Hrzn Biotec E2 USD | 904.51K | 1.73% | -79.83K |
| Janus Henderson Gbl Life Sciences Divers | 851.19K | 1.67% | 851.19K |
| Janus Henderson Global Life Sciences D | 865.42K | 1.57% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 16, 2026 | Bizily Scott | Chief Legal Officer | Sell | $20.99K |
| Oct 05, 2026 | Kirn David | See Remarks | Sell | $3.70K |
| Oct 05, 2026 | Kirn David | See Remarks | Sell | $750.24K |
| Sep 16, 2026 | Bizily Scott | Chief Legal Officer | Sell | $22.32K |
| Sep 14, 2026 | Kirn David | See Remarks | Sell | $811.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q4 | - | 2 |
| 2026 Q3 | - | 12 |
| 2026 Q2 | - | 4 |
| 2026 Q1 | - | 2 |
| 2025 Q4 | - | 7 |
FDMT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools